confirmed that CARD9 deficiency induces S100a8/a9 expression through toll-like receptors, leading to increased expression of pro-inflammatory, fibrotic, and lipid metabolism-related genes in NASH progression (50). The gene discussed is IGKV1D-22; the disease is metabolic dysfunction-associated steatohepatitis.